295 related articles for article (PubMed ID: 17369685)
21. Breast carcinoma metastasis to the esophagus: report of two cases.
Koike M; Akiyama S; Kodera Y; Nakao A
Hepatogastroenterology; 2005; 52(64):1116-8. PubMed ID: 16001642
[TBL] [Abstract][Full Text] [Related]
22. [A case of carcinoma of the esophagogastric junction with marked eosinophil infiltration].
Kokufu I; Yano T; Takatsuka Y; Kitani N; Kurata A; Kawahara T
Gan No Rinsho; 1986 Jan; 32(1):85-8. PubMed ID: 3005692
[TBL] [Abstract][Full Text] [Related]
23. [Cancer at the esophagogastric junction].
Natsugoe S; Aikou T
Gan To Kagaku Ryoho; 2005 Mar; 32(3):283-6. PubMed ID: 15791809
[TBL] [Abstract][Full Text] [Related]
24. Histopathologic classification of adenocarcinoma of the esophagogastric junction.
Baldus SE
Recent Results Cancer Res; 2010; 182():29-38. PubMed ID: 20676869
[No Abstract] [Full Text] [Related]
25. Gastroesophageal junction carcinoma multimodal treatment: standards, debate and new therapeutic options.
Liakakos T; Katsios C; Roukos DH
Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):1-4. PubMed ID: 21309665
[No Abstract] [Full Text] [Related]
26. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
27. A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity.
Adelstein DJ; Rice TW; Rybicki LA; Saxton JP; Videtic GM; Murthy SC; Zuccaro G; Vargo JJ; Dumot JA; Carroll MA
Am J Clin Oncol; 2007 Apr; 30(2):172-80. PubMed ID: 17414467
[TBL] [Abstract][Full Text] [Related]
28. Oesophagogastric junction adenocarcinoma: which therapeutic approach?
Mariette C; Piessen G; Briez N; Gronnier C; Triboulet JP
Lancet Oncol; 2011 Mar; 12(3):296-305. PubMed ID: 21109491
[TBL] [Abstract][Full Text] [Related]
29. Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland.
Carrillo JF; Vázquez R; Ramírez-Ortega MC; Cano A; Ochoa-Carrillo FJ; Oñate-Ocaña LF
Cancer; 2007 May; 109(10):2043-51. PubMed ID: 17410532
[TBL] [Abstract][Full Text] [Related]
30. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.
Ku GY; Ilson DH
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115
[TBL] [Abstract][Full Text] [Related]
31. A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectives.
Chiappa A; Andreoni B; Dionigi R; Spaggiari L; Foschi D; Polvani G; Orecchia R; Fazio N; Pravettoni G; Cossu ML; Galetta D; Venturino M; Ferrari C; Macone L; Crosta C; Bonanni B; Biffi R
Crit Rev Oncol Hematol; 2018 Dec; 132():161-168. PubMed ID: 30447922
[TBL] [Abstract][Full Text] [Related]
32. RE: Odze RD. unraveling the mystery of the gastroesophageal junction: a pathologist's perspective.
Chandrasoma P
Am J Gastroenterol; 2006 Jan; 101(1):199; author reply 199-200. PubMed ID: 16405557
[No Abstract] [Full Text] [Related]
33. [Role of papillomavirus in adenocarcinoma of esophagogastric junction].
Zhang J; Tian XY; Wu XJ; Zong XL; Wu J; Ji JF
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(32):2259-62. PubMed ID: 21029672
[TBL] [Abstract][Full Text] [Related]
34. Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors.
Mattioli S; Ruffato A; Di Simone MP; Corti B; D'Errico A; Lugaresi ML; Mattioli B; D'Ovidio F
Ann Thorac Surg; 2007 May; 83(5):1814-9. PubMed ID: 17462405
[TBL] [Abstract][Full Text] [Related]
35. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection.
Carboni F; Lorusso R; Santoro R; Lepiane P; Mancini P; Sperduti I; Santoro E
Ann Surg Oncol; 2009 Feb; 16(2):304-10. PubMed ID: 19050964
[TBL] [Abstract][Full Text] [Related]
36. Treatment results of adenocarcinoma of the gastroesophageal junction.
Yonemura Y; Kojima N; Kawamura T; Tsukiyama G; Bandou E; Sakamoto N; Tsubosa Y; Sato H
Hepatogastroenterology; 2008; 55(82-83):475-81. PubMed ID: 18613391
[TBL] [Abstract][Full Text] [Related]
37. Carcinoma of the esophagus in Tamil Nadu (South India): 16-year trends from a tertiary center.
Cherian JV; Sivaraman R; Muthusamy AK; Jayanthi V
J Gastrointestin Liver Dis; 2007 Sep; 16(3):245-9. PubMed ID: 17925916
[TBL] [Abstract][Full Text] [Related]
38. [Controversy on classification of cancers of the gastro-esophageal junction and its clinical significance].
Zhang X
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):76. PubMed ID: 16737630
[No Abstract] [Full Text] [Related]
39. Metastatic basal cell carcinoma: a case report and literature review. How accurate is our incidence data?
Wadhera A; Fazio M; Bricca G; Stanton O
Dermatol Online J; 2006 Sep; 12(5):7. PubMed ID: 16962022
[TBL] [Abstract][Full Text] [Related]
40. Carcinoma of the prostate presenting as a painful parotid mass with mandibular invasion: a case report.
Head CS; Hematpour K; Sercarz J; Luu Q; Bennett CJ
Ear Nose Throat J; 2009 Dec; 88(12):E7-8. PubMed ID: 20013668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
